Patent Yard Sign in
Canadian application, no grantCanada

Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof

CA 2480437 A1 · Owner: Fishel, Richard A. · Inventors: Fishel, Richard A.; Yoder, Kristine E.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Retroviruses are RNA viruses that must insert a DNA copy (cDNA) of their genome into the host genome in order to carryout a productive infection. One host cellular pathway that defends against retroviral cDNA integration involves highly conserved proteins of a host DNA repair pathway. These proteins represent novel targets for anti-retroviral drugs. The invention presented herein provides, inter alia, methods of identifying compounds that induce a DNA repair pathway and/or inhibit retroviral cDNA integration into a host genome, compounds thus identified uses of such compounds, and kits for , identifying and testing of the efficacy of compounds in inducing a DNA repair pathway, …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed April 4, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 4, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 4, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 4, 2003
GrantedNo grant recorded
Term endedApril 4, 2023
Patent numberCA 2480437 A1
Classification (IPC)C12N15/86 +2 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedApril 4, 2003Term endedApril 4, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.